King’s College London

King’s is one of the top 25 universities in the world, the fourth oldest university in England. King’s has over 29,600 students from some 150 countries and over 8,000 employees. King’s provides world-class teaching and cutting-edge research. In the 2014 Research Excellence Framework (REF) King’s was ranked 6th nationally in the ‘power’ ranking, which considers both the quality and quantity of research activity, and 7th for quality according to Times Higher Education rankings.

Eighty-four per cent of research at King’s was deemed ‘world-leading’ or ‘internationally excellent’ (3* and 4*). King’s has influenced many of the advances that shape modern life, such as the discovery of the structure of DNA, research that led to the development of radio, television, mobile phones and radar, medicine and healthcare, including antiseptic surgery and palliative care. It is the largest centre for the education of healthcare professionals in Europe.

Role in the project

Objective 1: Estimate the incidence and natural history, including recurrent stroke, after intracerebral haemorrhage (ICH)

• Identifying relevant data sets from Global Burden of Disease study and population data sets
• Estimate the incidence of ICH, the natural history in the first 2 years after stroke including risk of recurrence
• Project EU estimates over the next 20 years for ICH

Objective 2: Develop a health economic model to address the effects of the trial

• Identify data requirements for the health economic model to ensure they are recorded in the trial
• Build upon existing Markov and Discrete Event Simulation models developed by the study team (Saka et al, 2009) in previous European and UK studies
• Model the changes in the outcomes predicted given the trial working in the ‘real world’ situation